In 2023, France had a 12.36% share of scientific publications among the world’s top 10% cited in Applied Microbiology and Biotechnology. Over the years 2024 to 2028, forecasts indicate a gradual decline in this share: starting at 11.1% in 2024, down to 10.06% by 2028. The year-on-year variations suggest a consistent decrease of around 2.3% each year. The compound annual growth rate (CAGR) also reflects a contraction of approximately 2.5% over these five years.
Future trends to watch for:
- Impact of increased research funding and policy support on reversing the declining trend.
- France’s strategic collaborations globally to boost publication quality and citations.
- Technological innovations possibly leading to breakthroughs in biotechnology publication influence.